Financing pharmaceutical innovation : how much should poor countries contribute? (English)

A public economics framework is used to consider how pharmaceuticals should be priced when at least some of the research and development incentive comes from sales revenues. Familiar techniques of public finance are used to relax some of the restrictions implied in the standard use of Ramsey pricing. Under the more general model, poor countries should not necessarily cover even their own marginal costs, and the pricing structure is not related to...

DETAILS

Author

Jack,William G.;

Lanjouw,Jean O.;
Document Date
2005/01/01
Document Type
Journal Article
Report Number
77482
Volume No
1
Total Volume(s)
1
Country
World,
Region
Other,
Disclosure Date
2013/05/23
Disclosure Status
Disclosed
Doc Name
Financing pharmaceutical innovation : how much should poor countries contribute?
Keywords
marginal cost of production

DOWNLOADS

COMPLETE REPORT

Official version of document (may contain signatures, etc)

Official PDF
TXT*
Total Downloads** : 203
Download Stats
*The text version is uncorrected OCR text and is included solely to benefit users with slow connectivity.

Citation

Jack,William G.; Lanjouw,Jean O..

Financing pharmaceutical innovation : how much should poor countries contribute? (English). Washington DC ; World Bank. http://documents.worldbank.org/curated/en/656991468158713430

Financing pharmaceutical innovation : how much should poor countries contribute? (English)

DETAILS

DOWNLOADS

COMPLETE REPORT

Citation

SUBSCRIBE TO EMAIL ALERTS